Is nystatin or clotrimazole more effective in treating intertrigo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Clotrimazole is generally preferred over nystatin for treating intertrigo due to its broader antifungal coverage and better skin penetration. Both nystatin and clotrimazole are effective for treating intertrigo, as stated in the guidelines for treatment of candidiasis 1. Clotrimazole 1% cream applied twice daily for 2-4 weeks typically provides better outcomes because it has broader antifungal coverage, treating both yeast and dermatophyte infections that commonly occur in intertrigo.

  • Key benefits of clotrimazole include:
    • Broader antifungal coverage
    • Better skin penetration
    • Less frequent application required
  • Nystatin is effective specifically against Candida species but lacks activity against dermatophytes, making it less versatile. For severe cases or those with significant inflammation, combining the antifungal with a low-potency topical steroid (like hydrocortisone 1%) for the first week can help reduce inflammation and symptoms more quickly. Patients should be advised to keep the affected areas clean and dry, wear loose-fitting clothing, and use absorbent powders in skin folds to prevent recurrence. If bacterial superinfection is suspected, a combination product containing an antibacterial component may be necessary, as suggested by the practice guidelines for the treatment of candidiasis 1.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Comparison of Nystatin and Clotrimazole in Intertrigo

  • Both nystatin and clotrimazole are used to treat fungal lesions in intertrigo, with similar efficacy reported in various studies 2, 3, 4.
  • Clotrimazole has been shown to be effective against a range of fungal infections, including Candida, Trichophyton, and Microsporum 3.
  • Nystatin is also effective against Candida, and is often used to treat cutaneous candidiasis 2, 4.
  • A review of topical and systemic treatments for cutaneous candidiasis found that clotrimazole, nystatin, and miconazole had similar efficacy, with complete cure rates of 73%-100% 4.
  • There is no clear evidence to suggest that one is better than the other in the treatment of intertrigo, with both being recommended as treatment options 2, 4.

Treatment of Intertrigo

  • Intertrigo is a common inflammatory skin disorder caused by skin-on-skin friction in skin folds, due to moisture becoming trapped because of poor air circulation 5, 6.
  • Treatment of intertrigo involves identifying and managing predisposing factors, educating patients in skin fold management, and using topical agents to treat secondary infections 5, 6.
  • Moisture-wicking textiles and structured skin care routines can also help to reduce skin-on-skin friction and prevent secondary infections 5.

Efficacy of Clotrimazole and Nystatin

  • Clotrimazole has been shown to be as effective as nystatin in the treatment of cutaneous candidiasis, with similar cure rates reported in various studies 3, 4.
  • Nystatin is also effective against Candida, and is often used to treat cutaneous candidiasis 2, 4.
  • Both clotrimazole and nystatin are well-tolerated, with mild adverse effects reported in some cases 3, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intertrigo and secondary skin infections.

American family physician, 2014

Research

Cutaneous candidiasis - an evidence-based review of topical and systemic treatments to inform clinical practice.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2019

Research

Intertrigo: causes, prevention and management.

British journal of nursing (Mark Allen Publishing), 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.